Literature DB >> 22402362

The mechanisms of cerebral vascular dysfunction and neuroinflammation by MMP-mediated degradation of VEGFR-2 in alcohol ingestion.

P M Abdul Muneer1, Saleena Alikunju, Adam M Szlachetka, James Haorah.   

Abstract

OBJECTIVE: Blood-brain barrier (BBB) dysfunction caused by activation of matrix metalloproteinases (MMPs) is a pathological feature in vascular/neurological disease. We describe the mechanisms of BBB dysfunction and neuroinflammation as a result of MMP-3/9 activation and disruption of vascular endothelial growth factor (VEGF)-A/VEGFR-2 interaction, impairing effective angiogenesis. METHODS AND
RESULTS: We investigate the hypothesis in human brain endothelial cells and animal model of chronic alcohol ingestion. Proteome array analysis, zymography, immunofluorescence, and Western blotting techniques detected the activation, expression, and levels of MMP-3 and MMP-9. We found that degradation of VEGFR-2 and BBB proteins, for example, occludin, claudin-5, and ZO-1 by MMP-3/9, causes rupture of capillary endothelium and BBB leakiness. Impairment of BBB integrity was demonstrated by increased permeability of dye tracers and Fluo-3/calcein-AM-labeled monocyte adhesion or infiltration and decrease in transendothelial electric resistance. Alcohol-induced degradation of endothelial VEGFR-2 by MMP-3/9 led to a subsequent elevation of cellular/serum VEGF-A level. The decrease in VEGFR-2 with subsequent increase in VEGF-A level led to apoptosis and neuroinflammation via the activation of caspase-1 and IL-1β release. The use of MMPs, VEGFR-2, and caspase-1 inhibitors helped to dissect the underlying mechanisms.
CONCLUSIONS: Alcohol-induced MMPs activation is a key mechanism for dysfunction of BBB via degradation of VEGFR-2 protein and activation of caspase-1 or IL-1β release. Targeting VEGF-induced MMP-3/9 activation can be a novel preventive approach to vascular inflammatory disease in alcohol abuse.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22402362      PMCID: PMC3501346          DOI: 10.1161/ATVBAHA.112.247668

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  46 in total

1.  VEGFR2 translocates to the nucleus to regulate its own transcription.

Authors:  Inês Domingues; José Rino; Jeroen A A Demmers; Primal de Lanerolle; Susana Constantino Rosa Santos
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

2.  Overexpression of MMP-1 and MMP-3 by cultured conjunctivochalasis fibroblasts.

Authors:  D Q Li; D Meller; Y Liu; S C Tseng
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-02       Impact factor: 4.799

3.  Concentration of ethanol and other volatile compounds in the blood of acutely poisoned alcoholics.

Authors:  Dariusz Zuba; Wojciech Piekoszewski; Janusz Pach; Lidia Winnik; Andrzej Parczewski
Journal:  Alcohol       Date:  2002-01       Impact factor: 2.405

4.  Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier.

Authors:  M Fiala; Q N Liu; J Sayre; V Pop; V Brahmandam; M C Graves; H V Vinters
Journal:  Eur J Clin Invest       Date:  2002-05       Impact factor: 4.686

5.  High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.

Authors:  B Millauer; S Wizigmann-Voos; H Schnürch; R Martinez; N P Møller; W Risau; A Ullrich
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

6.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.

Authors:  F Shalaby; J Rossant; T P Yamaguchi; M Gertsenstein; X F Wu; M L Breitman; A C Schuh
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

7.  VEGF disrupts the neonatal blood-brain barrier and increases life span after non-ablative BMT in a murine model of congenital neurodegeneration caused by a lysosomal enzyme deficiency.

Authors:  Pampee P Young; Corinne R Fantz; Mark S Sands
Journal:  Exp Neurol       Date:  2004-07       Impact factor: 5.330

8.  Cortical spreading depression activates and upregulates MMP-9.

Authors:  Yasemin Gursoy-Ozdemir; Jianhua Qiu; Norihiro Matsuoka; Hayrunnisa Bolay; Daniela Bermpohl; Hongwei Jin; Xiaoying Wang; Gary A Rosenberg; Eng H Lo; Michael A Moskowitz
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

9.  Neurodegeneration in striatum induced by the mitochondrial toxin 3-nitropropionic acid: role of matrix metalloproteinase-9 in early blood-brain barrier disruption?

Authors:  Gyung W Kim; Yvan Gasche; Susanna Grzeschik; Jean-Christophe Copin; Carolina M Maier; Pak H Chan
Journal:  J Neurosci       Date:  2003-09-24       Impact factor: 6.167

10.  Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with suspected ovarian cancer.

Authors:  A Obermair; C Tempfer; L Hefler; O Preyer; A Kaider; R Zeillinger; S Leodolter; C Kainz
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

View more
  31 in total

Review 1.  New advances on glial activation in health and disease.

Authors:  Kim Mai Lee; Andrew G MacLean
Journal:  World J Virol       Date:  2015-05-12

2.  Peripheral immune factors are elevated in women with current or recent alcohol dependence and associated with altered mood and memory.

Authors:  Clare J Wilhelm; Bret E Fuller; Marilyn Huckans; Jennifer M Loftis
Journal:  Drug Alcohol Depend       Date:  2017-05-10       Impact factor: 4.492

3.  Inhibition of Caspase-1 Activation in Endothelial Cells Improves Angiogenesis: A NOVEL THERAPEUTIC POTENTIAL FOR ISCHEMIA.

Authors:  Jahaira Lopez-Pastrana; Lucas M Ferrer; Ya-Feng Li; Xinyu Xiong; Hang Xi; Ramon Cueto; Jun Nelson; Xiaojin Sha; Xinyuan Li; Ann L Cannella; Princess I Imoukhuede; Xuebin Qin; Eric T Choi; Hong Wang; Xiao-Feng Yang
Journal:  J Biol Chem       Date:  2015-06-02       Impact factor: 5.157

4.  MicroRNA in the Pathophysiology of CNS Injury: Implication in Neuroregenerative Medicine.

Authors:  P M Abdul-Muneer
Journal:  CNS Neurosci Ther       Date:  2016-07       Impact factor: 5.243

5.  Microglial activation is not equivalent to neuroinflammation in alcohol-induced neurodegeneration: The importance of microglia phenotype.

Authors:  S Alex Marshall; Justin A McClain; Matthew L Kelso; Deann M Hopkins; James R Pauly; Kimberly Nixon
Journal:  Neurobiol Dis       Date:  2013-01-08       Impact factor: 5.996

Review 6.  Erythropoietin: powerful protection of ischemic and post-ischemic brain.

Authors:  Anh Q Nguyen; Brandon H Cherry; Gary F Scott; Myoung-Gwi Ryou; Robert T Mallet
Journal:  Exp Biol Med (Maywood)       Date:  2014-03-04

7.  Microcystin-leucine-arginine causes blood-testis barrier disruption and degradation of occludin mediated by matrix metalloproteinase-8.

Authors:  Yabing Chen; Jing Wang; Chun Pan; Dongmei Li; Xiaodong Han
Journal:  Cell Mol Life Sci       Date:  2017-10-25       Impact factor: 9.261

Review 8.  Neuroinflammation and blood-brain barrier disruption following traumatic brain injury: Pathophysiology and potential therapeutic targets.

Authors:  Suraj Sulhan; Kristopher A Lyon; Lee A Shapiro; Jason H Huang
Journal:  J Neurosci Res       Date:  2018-09-27       Impact factor: 4.164

9.  Induction of oxidative and nitrosative damage leads to cerebrovascular inflammation in an animal model of mild traumatic brain injury induced by primary blast.

Authors:  P M Abdul-Muneer; Heather Schuetz; Fang Wang; Maciej Skotak; Joselyn Jones; Santhi Gorantla; Matthew C Zimmerman; Namas Chandra; James Haorah
Journal:  Free Radic Biol Med       Date:  2013-03-04       Impact factor: 7.376

10.  Traumatic brain injury-induced downregulation of Nrf2 activates inflammatory response and apoptotic cell death.

Authors:  Saurav Bhowmick; Veera D'Mello; Danielle Caruso; P M Abdul-Muneer
Journal:  J Mol Med (Berl)       Date:  2019-11-22       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.